The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, ...

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

Hologic Inc. closed 23.86% short of its 52-week high of $84.67, which the company reached on August 9th.

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

Minicarm.com: Your Go-To Source for Hologic Fluoroscan Mini C-Arm Sales, Parts & Service HAUPPAUGE, NEW YORK / ACCESS Newswire / February 4, 2025 / Hologic has officially announced the End-of-Sale and ...

(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...